Literature DB >> 12090557

Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?

Kevin J Harrington1, Christopher M Nutting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12090557

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN： 1472-4472


× No keyword cloud information.
  5 in total

1.  Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers.

Authors:  Kevin J Harrington; Eleni M Karapanagiotou; Victoria Roulstone; Katie R Twigger; Christine L White; Laura Vidal; Debbie Beirne; Robin Prestwich; Kate Newbold; Merina Ahmed; Khin Thway; Christopher M Nutting; Matt Coffey; Dean Harris; Richard G Vile; Hardev S Pandha; Johann S Debono; Alan A Melcher
Journal:  Clin Cancer Res       Date:  2010-05-18       Impact factor: 12.531

2.  The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis.

Authors:  Lucy Heinemann; Guy R Simpson; Nicola E Annels; Richard Vile; Alan Melcher; Robin Prestwich; Kevin J Harrington; Hardev S Pandha
Journal:  Mol Ther       Date:  2010-09-14       Impact factor: 11.454

3.  Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.

Authors:  Liam Welsh; Rafal Panek; Dualta McQuaid; Alex Dunlop; Maria Schmidt; Angela Riddell; Dow-Mu Koh; Simon Doran; Iain Murray; Yong Du; Sue Chua; Vibeke Hansen; Kee H Wong; Jamie Dean; Sarah Gulliford; Shreerang Bhide; Martin O Leach; Christopher Nutting; Kevin Harrington; Kate Newbold
Journal:  Radiat Oncol       Date:  2015-05-15       Impact factor: 3.481

4.  Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro.

Authors:  Geling Teng; Yuanrong Ju; Yepeng Yang; Hu Hua; Jingyu Chi; Xiuan Mu
Journal:  Mol Med Rep       Date:  2016-11-01       Impact factor: 2.952

Review 5.  From novel insights in molecular biology to targeted treatment approaches in head and neck cancer.

Authors:  Kevin J Harrington
Journal:  EJC Suppl       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.